Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity (Q39278572)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity |
scientific article |
Statements
1 reference
Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity (English)
1 reference
Kuen-Feng Chen
1 reference
Kuan-Chuan Pao
1 reference
Jung-Chen Su
1 reference
Yi-Chieh Chou
1 reference
Chun-Yu Liu
1 reference
Hui-Ju Chen
1 reference
Jui-Wen Huang
1 reference
InKi Kim
1 reference
Chung-Wai Shiau
1 reference
30 August 2012
1 reference
1 reference
Identifiers
1 reference